General And Administrative Expense of NYMOX PHARMACEUTICAL CORP from 31 Mar 2021 to 30 Sep 2024

Taxonomy & unit
ifrs-full: USD
Summary
NYMOX PHARMACEUTICAL CORP quarterly General And Administrative Expense in USD history and change rate from 31 Mar 2021 to 30 Sep 2024.
  • NYMOX PHARMACEUTICAL CORP General And Administrative Expense for the quarter ending 30 Sep 2024 was $142,000, a 60% decline year-over-year.
Source SEC data
View on sec.gov
General And Administrative Expense, Quarterly (USD)
General And Administrative Expense, YoY Quarterly Change (%)

NYMOX PHARMACEUTICAL CORP Quarterly General And Administrative Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $142,000 -$211,000 -60% 01 Jul 2024 30 Sep 2024 6-K 02 Jan 2025 2024 Q3
Q3 2023 $353,000 -$233,000 -40% 01 Jul 2023 30 Sep 2023 6-K 02 Jan 2025 2024 Q3
Q2 2023 $505,000 -$458,000 -48% 01 Apr 2023 30 Jun 2023 6-K 14 Aug 2023 2023 Q2
Q1 2023 $665,000 -$75,000 -10% 01 Jan 2023 31 Mar 2023 6-K 12 May 2023 2023 Q1
Q3 2022 $586,000 -$869,000 -60% 01 Jul 2022 30 Sep 2022 6-K 15 Nov 2023 2023 Q3
Q2 2022 $963,000 -$949,000 -50% 01 Apr 2022 30 Jun 2022 6-K 14 Aug 2023 2023 Q2
Q1 2022 $740,000 -$264,000 -26% 01 Jan 2022 31 Mar 2022 6-K 12 May 2023 2023 Q1
Q3 2021 $1,455,000 01 Jul 2021 30 Sep 2021 6-K/A 16 Nov 2022 2022 Q3
Q2 2021 $1,912,000 01 Apr 2021 30 Jun 2021 6-K 15 Aug 2022 2022 Q2
Q1 2021 $1,004,000 01 Jan 2021 31 Mar 2021 6-K 13 May 2022 2022 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.